Clinical Trial Update: Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether consolidating with bortezomib after high-dose melphalan with stem cell support improves outcomes in multiple myeloma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• Melphalan (Melphalan)

Snippet

Sponsor: Nordic Myeloma Study Group | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED